Glenmark Life Sciences Limited IPO opened for public subscription today (Tuesday, July 27, 2021). The IPO that comes in the price range of Rs 695 to Rs 720 will conclude on July 29, 2021. Minimum investment required for Glenmark Life Sciences Limited IPO is Rs 13,900 and it comprises a lot size of 20. Glenmark Life Sciences Limited IPO issue size has been fixed at Rs 1513.60 crore.      

See Zee Business Live TV Streaming Below:

Though Glenmark Life Sciences Limited IPO will open for subscription on genral demat account and other platforms from Tuesday, there are certain apps and platforms that had enabled preopen subscription in advance. A pre-apply feature enables investors to invest in an IPO 3 to 4 days in advance.    

Glenmark Life Sciences Limited IPO Key Dates   

Glenmark Life Sciences Limited IPO last date : July 29, 2021  

Glenmark Life Sciences Limited IPO allotment finalisation: August 3, 2021  

Glenmark Life Sciences Limited IPO refund Initiation: August 4, 2021  

Glenmark Life Sciences Limited IPO listing date: August 6, 2021  

Glenmark Life Sciences Limited IPO IMPORTANT Details  

Glenmark Life Sciences Limited IPO Issue size: A fresh issue of equity shares worth Rs 1,060 crore and an offer for sale by existing shareholders worth Rs 453 crore 

Glenmark Life Sciences Limited IPO Price Band: Rs 695 to Rs 720 per equity share.  

Glenmark Life Sciences Limited IPO lot size: 20 equity shares and in multiples of 20 equity shares thereafter.   

Glenmark Life Sciences Limited IPO Price purchase limit on UPI: Rs 2 lakh per transaction   

Glenmark Life Sciences Limited IPO Price Band size Issue type: Book Building Process.   

Glenmark Life Sciences Limited IPO offer allocation:  15 per cent for Non-Institutional Bidders and 35 per cent Retail Individual Investors.  

Glenmark Life Sciences Limited is a subsidiary of Glenmark Pharmaceuticals Limited. The parent company is a leading developer and manufacturer of select high-value , non-commoditized active pharmaceutical ingredients (APIs).